- Home
- New Medical Device Regulation
New Medical Device Regulation Training Course
Managing the transition to the new regulation: this is a seminar you cannot afford to miss as you put in place your strategies for the new environment.
Details
Course overview
During a period of great uncertainty and opportunity within the medical technology and diagnostics sectors, this seminar will help you prepare for these changes and operate successfully in Europe. The programme will provide in-depth coverage of the new regulations and how they will be implemented by member states and Notified Bodies. You will hear the latest thoughts on clinical development, safety monitoring, the role of authorised representatives, economic operators, and
the implications of Brexit.
There will be plenty of opportunities to discuss the implications of the changes with our expert faculty, and you will gain valuable guidance on successful implementation of the regulatory changes for your company products.
This is a seminar you cannot afford to miss as you put in place your strategies for the new environment.
Who should attend
- Regulatory affairs
- Clinical studies
- Vigilance
- PMS
- Quality systems
- Technical support and business development.
Why you should attend
The seminar will provide key guidance and interpretation of the changes to the regulations and will be of value to all those who are involved with placing a medical device on the market, and anyone who requires an essential overview of the new MDR and its impact on the industry and working practices.
Programme
Introduction and background to the new regulation
- Medical Device Coordination Groups
Dr David Jefferys
Successful implementation of the MDR
- Managing the urgency – time and resources are tight
- What you really need to know – how to meet the key requirements
- Clinical evidence – don’t underestimate its importance
- The B word (Brexit)
Peter Rose
Notified Bodies: how the changes will impact NBs and manufacturers – including the new rules for IVD conformity assessment
- Accreditation and designation of NBs
- How to register with NBs
- Conformity assessment applications
Theresa Jeary
Increased vigilance and post-market surveillance − how to comply
- Post-market surveillance systems appropriate for your device and risk classification
- Periodic safety update reports (PSURs)
- Manufacturers’ response times to serious public health threats and deaths caused by devices
Dr David Jefferys
IVDs and companion diagnostics Implications and timelines
- Implications and timelines
- New IVD conformity assessment rules
Theresa Jeary
Clinical investigations − what is required?
- Greater protection for patients participating in clinical investigations
- Products to have an acceptable benefit to risk ratio
- Product safety and performance
- Changes in data requirements
- Restrictions by individual member states
Janette Benaddi
Other essential considerations
- Authorised representatives – increased responsibilities and requirements
- Single registration numbers for all economic operators
- New categories
- Single-use devices – reprocessing?
- Unique device identification
- Safety and clinical performance summaries
- Strategies to address the new requirements
Dr David Jefferys
Presenters
Janette Benaddi (More...)
Janette Benaddi is a business mentor, international speaker/trainer and consultant to the medical device industry. Janette has over 25 years’ experience of managing pre and post market clinical studies in both devices and pharmaceuticals. Janette has worked with several multinational organizations in various clinical, regulatory and marketing roles.
She has extensive experience of conducting clinical studies with medical device products as well as regulatory expertise for CE marking of devices. Specifically she has been involved in writing and reviewing hundreds of Clinical evaluation reports for the medical device industry, she has also provided training to Notified bodies in this subject.
Janette qualified as a registered nurse in 1984, she has a BSc in Management studies, a Diploma in Company Direction, and a Diploma in Management studies, holds a teaching certificate and is a Chartered Scientist and Chartered Director. Janette sits on several committees in the device community and industry and has been an instrumental advocate of improving and advancing medical device research in the UK. Janette has published several articles relating to medical device regulation and clinical studies.
Theresa Jeary (More...)
Theresa Jeary holds a Master’s Degree in Pharmaceutical Science and is eligible to be a Pharmaceutical Qualified Person. Theresa has over 25 years’ experience working in both the Pharmaceutical and Medical Device industries and has worked in a variety of roles across the full development cycle from product concept and early stage development, process transfer, validation and regulatory departments, and has been involved in the development of many commercially available medicinal and medical device products.
She has over 10 years Notified Body experience working at BSi as a technical expert and until January held the position of Head of Notified Body at LRQA. Her area of technical expertise is in device-drug combinations and borderline classifications, and she has completed many successful consultations in this area with many European Competent Authorities and EMA.
Theresa now works as a consultant to the Pharmaceutical and Medical device sectors and is a frequently invited speaker on medical device legislation and combination products.
David Jefferys (More...)
Dr David Jefferys is Senior Vice President for Global Regulatory, Government Relations, Public Affairs and Patient Safety (EMEA, Russia and Australasia) at Eisai. After qualifying, he worked in clinical and academic medicine before spending 20 years as a senior regulator for both medicines and medical devices.
He was executive director of the UK Medicines Control Agency, CEO and Director of the MDA and joint CEO of the MHRA. He was involved in the establishment of the European Medicines Agency, is a CPMP/CHMP member and Chair of the MRFG and PER scheme. For the last ten years he has worked in industry and chairs several key committees for ABPI,EFPIA and IFPMA.
Book now
Book now
|
12-13 Oct 2021 Live webinar |
|||
|
12-13 Oct 2021 Live webinar |
GBP 1,299 1,099 EUR 1,859 1,579 USD 2,098 1,786 Until 31 Aug* |
Enrol now
to attend Live webinar |
|
|
14-15 Oct 2021 Face-to-face, (venue not yet confirmed) |
|||
|
14-15 Oct 2021 Face-to-face (venue not yet confirmed) |
GBP 1,499 1,299 EUR 2,099 1,819 USD 2,338 2,026 Until 2 Sep* |
Enrol now
to attend Face-to-face (venue not yet confirmed) |
|
Learn more about our face-to-face and webinar training formats.
* Note the early booking discount cannot be combined with any other offers or promotional code